California Scientific  *  BrainMaker Neural Network Software  *   800-284-8112 * 916-372-6800
California Scientific      BrainMaker Neural Network Software
Home Applications What Are Neural Networks Products Ordering Info Tech Support
Applications

Stocks
Currency Predictions
Corporate Bonds
S&P 500 Index
Stock Price Prediction
Stock Prophet
Natural Gas Prices

Business
Direct Mail
Credit Scoring
Real Estate Appraisal
Bad Cops
Finding Gold
Jury Summoning
Highway Maintenance

Medical
Breast Cancer
Hospital Expenses
Functional Recovery
Heart Attack Diagnosis
ER Test ordering
Psychiactric Care
Giant Cell Arteritis

Sports
Thoroughbreds
Thoroughbreds 1
Dog Racing

Science
Solar Flares
Protein Sequencing
Mosquito Identification
Spectroscopy
Weather Forecasting
Predicting El Nino
Air Quality

Manufacturing
Welding Quality
Plastics Testing
IC Quality Control
Paper Quality
Concrete Testing
Beer Quality
Enzyme Synthesis
Steam Quality

Pattern Recog.
Speech Recognition
Article Classification
Working with Chaos
Chemical Drawings
Sequence Prediction

Classify Breast Cancer Cells with BrainMaker Neural Network Software

Breast cancer cells are traditionally examined under a microscope by a human, who decides the degree of cancer present. People are inconsistent in these judgements from day to day and from person to person.

A BrainMaker neural network that classifies breast cancer cells has been developed. The system was developed by Andrea Dawson, MD of the University of Rochester Medical Center, Richard Austin, MD of the University of California at San Francisco, and David Weinberg, MD, PhD of the Brigham and Womens' Hospital and Harvard Medical School of Boston. Initial comparisons showed that BrainMaker is in good agreement with human observer cancer classifications.

Cancer cells are measured with the CAS-100 (Cell Analysis System, Elmhurst, IL). There are 17 inputs to the neural network which represent morphometric features such as density and texture. There are four network outputs representing nuclear grading. The cancerous nucleus is graded as being well, moderate, or poorly differentiated, or as benign. Correct grade assignments were made between 52% and 89% of the time on cases not seen during training. The lower success rate (for well differentiated) may have been due to the smaller percentage of this type in the training set. In addition, heterogeneity is much lower in well-differentiated tumors. Cancerous nuclei were classified within one grade of the correct grade.

INPUTS object size
object shape
object sum density
object average density
object texture
angular second moment
contrast
difference moment
sum variance
difference variance (Fisher)
difference entropy
information measure B
maximum correlation coefficient
difference variance
diagonal moment
second diagonal moment
product moment

OUTPUTS
well differentiated
moderate
poor
benign

Home Applications What Are Neural Networks Products Ordering Info Tech Support
California Scientific      BrainMaker Neural Network Software

California Scientific
Sales@CalSci.com • 800-284-8112 • 916-372-6800